Analysts Offer Insights on Healthcare Companies: Humacyte (HUMA) and Ligand Pharma (LGND)

TipRanks17minutes ago · Ratings

Express News | Humacyte Inc : Benchmark Raises Target Price to $17 From $15

Breakings43minutes ago

12 Health Care Stocks Moving In Friday's Pre-Market Session

BenzingaDec 21 05:06

TD Cowen Maintains Humacyte(HUMA.US) With Buy Rating, Maintains Target Price $10

Futu NewsDec 21 03:31 · Ratings

BTIG Maintains Humacyte(HUMA.US) With Buy Rating, Maintains Target Price $10

Futu NewsDec 21 02:31 · Ratings

H.C. Wainwright Maintains Humacyte(HUMA.US) With Buy Rating, Raises Target Price to $15

Futu NewsDec 21 02:31 · Ratings